Mar 08 2017

Blunt-Led Hearing Highlights Importance of Investing in Medical Research

Features Testimony from Dr. Timothy Eberlein of St. Louis’ Siteman Cancer Center

WASHINGTON – U.S. Senator Roy Blunt (Mo.), chairman of the Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, today questioned a panel of expert medical researchers, including Dr. Timothy Eberlein, Director of the Siteman Cancer Center in St. Louis, about the importance of medical research at the National Institutes of Health. Last year, Blunt secured the largest funding increase in the Labor/HHS appropriations bill NIH had received in over a decade.

As chairman, Blunt delivered opening remarks highlighting the benefits of medical research at the National Institutes of Health, and reaffirmed that federal funding is an essential component of the progress that has advanced the understanding of disease, raised life expectancy, and improved the quality of life for patients and their families.

Blunt questioned Dr. Eberlein regarding the accurate diagnosis and treatment of breast cancer. Blunt also questioned Dr. Thomas Grabowski, Director of the University of Washington Medicine Memory and Brain Wellness Center, regarding the projected costs of treating Alzheimer’s disease.

Blunt’s opening remarks can be seen here.